Table 2.
Effect of urinary iodine concentration on thyroid nodule according to the iodine nutritional status evaluation criteria of the WHO.
| Group | UIC (μg l−1) | Model 1a | Model 2b | Model 3c | Model 4d | ||||
|---|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | ||
| All | <100 | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| 100–199 | 0.75 (0.58–0.97) | 0.03 | 0.75 (0.58–0.97) | 0.03 | 0.78 (0.61–1.01) | 0.06 | 0.79 (0.61–1.03) | 0.08 | |
| 200–299 | 0.54 (0.39–0.75) | 0.00 | 0.54 (0.39–0.75) | 0.00 | 0.62 (0.44–0.87) | 0.01 | 0.63 (0.45–0.88) | 0.01 | |
| ≥300 | 0.50 (0.34–0.76) | 0.00 | 0.51 (0.34–0.77) | 0.00 | 0.61 (0.40–0.92) | 0.02 | 0.62 (0.41–0.94) | 0.03 | |
|
| |||||||||
| Male | <100 | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| 100–199 | 0.83 (0.56–1.23) | 0.34 | 0.82 (0.55–1.22) | 0.33 | 0.84 (0.56–1.25) | 0.38 | 0.84 (0.56–1.25) | 0.39 | |
| 200–299 | 0.55 (0.34–0.91) | 0.02 | 0.55 (0.34–0.91) | 0.02 | 0.63 (0.38–1.04) | 0.07 | 0.63 (0.38–1.04) | 0.07 | |
| >300 | 0.67 (0.37–1.20) | 0.18 | 0.68 (0.38–1.21) | 0.19 | 0.84 (0.47–1.52) | 0.57 | 0.85 (0.47–1.53) | 0.58 | |
|
| |||||||||
| Female | <100 | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| 100–199 | 0.71 (0.51–0.98) | 0.04 | 0.71 (0.51–0.98) | 0.04 | 0.75 (0.54–1.05) | 0.09 | 0.77 (0.55–1.07) | 0.12 | |
| 200–299 | 0.54 (0.35–0.83) | 0.01 | 0.54 (0.35–0.84) | 0.01 | 0.62 (0.40–0.97) | 0.04 | 0.63 (0.40–0.98) | 0.04 | |
| ≥300 | 0.39 (0.22–0.70) | 0.00 | 0.40 (0.22–0.70) | 0.00 | 0.46 (0.25–0.82) | 0.01 | 0.47 (0.26–0.85) | 0.01 | |
aAdjusted for gender, age (continuous variable), education, and profession.bAdditionally adjusted for hypertension.cAdditionally adjusted for BMI, waist circumference, FBG, OTGG-2h, HbA1c, TC, LDL-C, and UA.dAdditionally adjusted for TSH and TGAb.